Skip to main content

September 2017

 

 

academics

 

Clinical research courses

The Zika virus (ZIKV) may infect and kill a specific type of brain cancer cells while leaving normal adult brain tissue minimally affected, according to a new study supported by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health. In the paper, published online on September 5 in The Journal of Experimental Medicine, researchers describe the impact of ZIKV on glioblastoma cells in both human tissue samples and mice.

Job for M.Pharm as Research Associate in Pharmaceutical Development at Aurigene

Aurigene is a Bangalore based world-class drug discovery company with integrated capabilities for discovery and development of novel small molecule drugs. Aurigene provides Drug Discovery Services for Lead Generation/ Lead Optimization. The Business Model involves collaborative Drug Discovery with partners, on a risk- and reward-sharing basis. Typical Aurigene projects involve starting with a partner's target protein and delivering an Optimized Lead, ready to go into clinical development. Aurigene is founded by Dr Reddy's Laboratories Limited (DRL). DRL is listed both on the New York Stock Exchange (NYSE) and Bombay Stock Exchange (BSE) with significant operations in USA and Europe.

Post : Research Associate

Walk in interview for Fresher M.Pharm, B.Pharm, M.Sc at Hetero Drugs

Hetero Drugs established in the year 1993, with the motto to be the best in the API manufacturing, Hetero today embodies the vision of a top notch player in developing and commercialising products catering to a variety of therapeutic categories, integrating into a leading finished dosage manufacturer.
True to the Statement, "Where the Future Started Yesterday", with a foresight on the current trends in the Pharmaceutical Market, Hetero has grown from strength to strength, combining its Research Strengths, Manufacturing Capabilities ,Human Resources and well established quality management system.

Walk in interview for Analysts and QA & QC Officers at Cipla

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country. Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.

Post : Analysts and QA Officers

Faculty Recruitment in Pharmacy Practice at Teerthanker Mahaveer University

The Teerthanker Mahaveer University, established by an ‘Act’ (No. 30) of 2008 of the Government of Uttar Pradesh, and approved by the University Grants Commission (UGC), since inception in 2008, vide letter No. F. 9-31/2008(CPP-1) dated October, 2008.  The university is located on National Highway-24, barely 144 Km from New Delhi. The University stands committed to the ideals of Lord Mahaveer – Right Philosophy, Right Knowledge, and Right Conduct – in all spheres of activity and aspires to be recognized as the ultimate destination for world-class education.

Post : Faculty Jobs

Walk in interview in Quality Assurance and Quality Control at Cipla

Cipla known for its innovative pharmaceutical products backed by latest in technology and creative marketing practices, is enjoying a commanding position among the top pharma companies in the country.
Several specialised therapeutic divisions and promising new products have been launched and many more are in the pipeline.

Post : officers

AN OVERVIEW ON POLYMERIC NANOPARTICLESUSED IN THE TREATMENT OF DIABETES MELLITUS

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
K.GOPALASATHEESKUMAR1*, S.KOMALA2 AND M.MAHALAKSHMI2
1KMCH college of Pharmacy, Kovai Estate, Kalapatti Road, Coimbatore-641048, Tamil Nadu, India.
2Jaya College of Paramedical sciences, College of Pharmacy, Thiruninravur, Chennai – 602024, Tamil Nadu, India.
*gskpungai@gmail.com

ABSTRACT 
The review was carried out to discuss in detail about the polymeric nanoparticles for diabetic treatment. The diabetes is the chronic metabolic disorder characterized by the deficiency of insulin production. The various treatments are available for the diabetes and the nanoparticles are having the several advantages. The various types of nanoparticles are available for the anti-diabetic drugs; the polymeric nanoparticles are the one of the most commonly used nanoparticles. The polymeric nanoparticles are commonly 10-1000nm in size. The polymeric nanoparticles are formulated by drug with the polymers. The main advantages of the polymeric nanoparticles are the simplest preparation method, targeted delivery, the minimizing of the dose and high therapeutic efficiency. In this review was mainly can be focused on advantages, disadvantages of polymeric nanoparticles, various polymers, various formulation techniques, diabetes disease profile, insulin production, various anti-diabetic drugs and the polymeric nanoparticle formulation of anti-diabetic drugs.

Recruitment for Pharmacists (20 posts) in JRHMS | Government Jobs

The National Health Mission (NHM) was launched with a view to bring about dramatic improvements to the health system and health status of people, especially those who live in the rural areas of the country.